Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last ¥2,660 JPY
Change Today -319.00 / -10.71%
Volume 1.1M
As of 2:00 AM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

carna biosciences inc (4572) Snapshot

Open
¥2,970
Previous Close
¥2,979
Day High
¥2,970
Day Low
¥2,660
52 Week High
07/23/15 - ¥6,030
52 Week Low
02/5/15 - ¥650.00
Market Cap
23.6B
Average Volume 10 Days
1.5M
EPS TTM
¥6.96
Shares Outstanding
8.9M
EX-Date
--
P/E TM
382.2x
Dividend
--
Dividend Yield
--
Current Stock Chart for CARNA BIOSCIENCES INC (4572)

Related News

No related news articles were found.

carna biosciences inc (4572) Related Businessweek News

No Related Businessweek News Found

carna biosciences inc (4572) Details

Carna Biosciences, Inc. provides drug discovery supporting products and services in Japan. Its products and services include kinase proteins; biotinylated kinases to use in the study of kinase-molecule interactions; profiling services; live-cell kinase assemblies that offer tyrosine kinase profiling and screening services; ClariCELL kinase cell-based assembly services; and co-crystallography services and crystal grade proteins. The company’s drug discovery supporting products and services also comprise assay development services, such as kinase genetic cloning, kinase protein production, substrate search optimization, and assay optimization services; and protein substrates to use for kinase assemblies. It also identifies and develops medicines primarily for the treatment of cancer and inflammatory diseases using its QuickScout drug discovery platform. The company was founded in 2003 and is based in Kobe, Japan.

49 Employees
Last Reported Date: 03/25/15
Founded in 2003

carna biosciences inc (4572) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

carna biosciences inc (4572) Key Developments

Carna Biosciences, Inc. Announces Consolidated Earnings Results for the Second Quarter Ended June 30, 2015; Provides Earnings Guidance for the Full Year Ending December 31, 2015

Carna Biosciences, Inc. announced consolidated earnings results for the second quarter ended June 30, 2015. For the quarter, the company reported total revenue of JPY 1,134 million compared to JPY 306 million a year ago. Operating income was JPY 679 million compared to loss of JPY 277 million a year ago. Ordinary income was JPY 704 million compared to loss of JPY 257 million a year ago. Net income was JPY 666 million or JPY 78.73 per share compared to loss of JPY 257 million or JPY 31.19 per share a year ago. For the full year ending December 31, 2015, the company expects JPY 1,532 million and operating income of JPY 372 million. Ordinary income of JPY 395 million. Net income of JPY 364 million. Net income per share of JPY 42.03.

Carna Biosciences, Inc., Q2 2015 Earnings Call, Aug 11, 2015

Carna Biosciences, Inc., Q2 2015 Earnings Call, Aug 11, 2015

Carna Biosciences, Inc. to Report Q2, 2015 Results on Aug 07, 2015

Carna Biosciences, Inc. announced that they will report Q2, 2015 results on Aug 07, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4572:JP ¥2,660.00 JPY -319.00

4572 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4572.
View Industry Companies
 

Industry Analysis

4572

Industry Average

Valuation 4572 Industry Range
Price/Earnings 100.0x
Price/Sales 18.0x
Price/Book 12.5x
Price/Cash Flow 236.3x
TEV/Sales 17.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CARNA BIOSCIENCES INC, please visit www.carnabio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.